Assistant Professor at the College of Pharmacy, Dr. Iman Ali Saeed, obtained a patent to be able to extract and purify the toxin similar to Shika 2 isolated from the hemorrhagic Escherichia coli serotype O157:H7 and study its histological effects for the first time in Iraq: as an initial step for the treatment of bloody diarrhea in children The patent included a study of the hemorrhagic bacterium Escherichia coli of the serotype O157:H7, which is one of the important causes of bloody diarrhea in children under five years of age. Shiga-like toxin 1 and 2 and that the extraction and purification of Shiga-like toxin 2 is an initial step for the treatment of bloody diarrhea in children.
The patent aimed to extract and purify Shiga-like toxin 2 and study its histological effects for the first time in Iraq, which is an initial step for treating bloody diarrhea in children by using it as an antitoxin or to produce specialized antibodies to the purified poison.
